Blood Plasma Derivatives Market PPT 2024: Size, Growth, Demand and Forecast till 2032

1
Global Blood Plasma Derivatives Market Research
and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Blood Plasma Derivatives Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global blood plasma
  derivatives market size reached US 45.8 Billion
  in 2023.
• Blood plasma derivatives are concentrated forms
  of specific proteins made from plasma collected
  through fractionation. They are commonly used to
  kill viruses that cause hepatitis B, hemophilia
  A, bleeding disorders, immunodeficiency,
  hepatitis C, hypogammaglobulinemia, hemophilia B,
  and human immunodeficiency virus (HIV), as they
  are rich in proteins, minerals, salts, hormones,
  vitamins, and protease inhibitors. Some commonly
  used blood plasma derivatives include factor
  VIII, immunoglobulin, albumin, hyperimmune
  globulin, factor IX, and fresh frozen.
• They help improve nutrition, control body
  temperature and blood clotting, maintain osmotic
  pressure, enhance respiration and excretion, and
  control acid-base balance. At present, blood
  plasma derivatives are commonly stored at
  diagnostic centers, hospitals, clinics, and blood
  transfusion centers across the globe.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/blood-plasma-derivative
  s-market/requestsample

4
Report Description

• Global Blood Plasma Derivatives Market Trends
• The rising prevalence of infectious diseases and
  the expanding geriatric population represent the
  primary factors driving the market growth.
  Moreover, the surging adoption of blood plasma
  derivatives to treat coronavirus disease
  (COVID-19) patients by convalescent plasma
  treatment is positively influencing the market
  growth. Apart from this, numerous technological
  advancements in the fractionation process that
  help separate blood plasma components and protein
  concentrates for clinical use are propelling the
  market growth. Additionally, continual
  improvements in existing procedures and the
  development of novel preservation techniques to
  produce targeted therapeutic products are other
  major growth-inducing factors. Besides this, the
  escalating demand for blood plasma derivatives
  due to the rise in the prevalence of
  life-threatening diseases, such as
  immunodeficiency disorders and hemophilia, has
  catalyzed market growth. This can be attributed
  to the presence of immunoglobins in blood plasma
  that are essential for the development of
  immunity and for maintaining the osmotic pressure
  in blood vessels, which further slows the onset
  of hemophilia and immune deficiency disorders.
  Other factors, including the rising awareness
  regarding blood and plasma donation, favorable
  government initiatives to promote blood donation
  camps, and rapid growth in the healthcare
  industry, are also anticipated to create a
  positive market outlook.
• Looking forward, IMARC Group expects the market
  value to reach US 74.1 Billion by 2032,
  expanding at a CAGR of 5.4 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/blood-plasma-derivative
  s-market

5
Report Segmentation

• Breakup by Type
• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Others
• Breakup by Application
• Hemophilia
• Hypogammaglobulinemia
• Immunodeficiency Diseases
• Von Willebrand's Disease
• Others

6
Report Segmentation

• Breakup by End User
• Hospitals
• Clinics
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Baxter International Inc.
• Bayer AG
• CSL Limited
• Fusion Health Care Pvt. Ltd.
• Grifols S.A.
• Kedrion S.p.A.
• LFB S.A.
• Octapharma AG
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Blood Plasma
  Derivatives Market    5.1    Market Overview   
  5.2    Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type
• 6.1 Albumin
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Factor VIII
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Factor IX
• 6.3.1 Market Trends
• 6.3.2 Market Forecast       

10
Table of Contents

• 6.4 Immunoglobulin
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 6.5 Hyperimmune Globulin
• 6.5.1 Market Trends
• 6.5.2 Market Forecast
• 6.6 Others
• 6.6.1 Market Trends
• 6.6.2 Market Forecast
• 7 Market Breakup by Application
• 7.1 Hemophilia
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Hypogammaglobulinemia
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Immunodeficiency Diseases
• 7.3.1 Market Trends
• 7.3.2 Market Forecast

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com